Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to 7.89%.

  • Select Medical Holdings' EBITDA Margin rose 10300.0% to 5.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.46%, marking a year-over-year increase of 40100.0%. This contributed to the annual value of 7.89% for FY2024, which is 4200.0% down from last year.
  • As of FY2024, Select Medical Holdings' EBITDA Margin stood at 7.89%, which was down 4200.0% from 8.32% recorded in FY2023.
  • In the past 5 years, Select Medical Holdings' EBITDA Margin ranged from a high of 14.3% in FY2021 and a low of 5.97% during FY2022
  • Moreover, its 5-year median value for EBITDA Margin was 7.89% (2024), whereas its average is 8.53%.
  • Per our database at Business Quant, Select Medical Holdings' EBITDA Margin soared by 81000bps in 2021 and then tumbled by -83300bps in 2022.
  • Over the past 5 years, Select Medical Holdings' EBITDA Margin (Annual) stood at 6.19% in 2020, then soared by 131bps to 14.3% in 2021, then crashed by -58bps to 5.97% in 2022, then surged by 39bps to 8.32% in 2023, then fell by -5bps to 7.89% in 2024.
  • Its EBITDA Margin was 7.89% in FY2024, compared to 8.32% in FY2023 and 5.97% in FY2022.